Xiaoxuan Tu
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Weijia Fang (11 shared papers)Weiqin Jiang (4 shared papers)Yi Zheng (5 shared papers)Hangyu Zhang (5 shared papers)Peng Zhao (3 shared papers)Tingting Wang (1 shared paper)Yun Huang (1 shared paper)Peilu Li (1 shared paper)
In The Last Decade
Xiaoxuan Tu
12 papers receiving 617 citations
Xiaoxuan Tu's Hit Papers
Peers
Comparison fields: 5 of 70
- Oncology 292
- Hepatology 81
- Biological Psychiatry 19
- Immunology 92
- Molecular Biology 278
Countries citing papers authored by Xiaoxuan Tu
This map shows the geographic impact of Xiaoxuan Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxuan Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxuan Tu more than expected).
Fields of papers citing papers by Xiaoxuan Tu
This network shows the impact of papers produced by Xiaoxuan Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxuan Tu. The network helps show where Xiaoxuan Tu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxuan Tu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gut microbiome affects the response to anti-PD-1 immunotherapy in patients with hepatocellular carcinoma Hit paper breakdown → | 2019 | 406 |
| 2 | 2022 | 60 | |
| 3 | 2018 | 53 | |
| 4 | 2020 | 23 | |
| 5 | 2020 | 23 | |
| 6 | 2019 | 14 | |
| 7 | 2024 | 13 | |
| 8 | 2024 | 11 | |
| 9 | 2021 | 10 | |
| 10 | 2025 | 5 | |
| 11 | 2025 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2025 | 0 |
About Xiaoxuan Tu
Xiaoxuan Tu is a scholar working on Surgery, Oncology, Immunology, Molecular Biology and Genetics, having authored 13 papers that have together received 623 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Virus-based gene therapy research (2 papers), Intraperitoneal and Appendiceal Malignancies (1 paper), Viral Infectious Diseases and Gene Expression in Insects (1 paper), thermodynamics and calorimetric analyses (1 paper), Immunotherapy and Immune Responses (1 paper), Force Microscopy Techniques and Applications (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Oncology (292 citations), Hepatology (81 citations), Biological Psychiatry (19 citations), Immunology (92 citations) and Molecular Biology (278 citations). Xiaoxuan Tu has collaborated with scholars based in China, Canada and Australia. Frequent co-authors include Weijia Fang, Weiqin Jiang, Yi Zheng, Hangyu Zhang, Peng Zhao, Tingting Wang, Yun Huang, Peilu Li, Ruixue Song and Shunfeng Cai. Their work appears in journals such as Journal for ImmunoTherapy of Cancer, Cancer Gene Therapy, Frontiers in Oncology, Journal of Inflammation Research and Cancer Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.